EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours

Hunter J Piegols, Brittany E Abrams, Janis M Lapsley, Megan T Cray, Josephine A Dornbusch, Christina Murphy, Brandan G Wustefeld-Janssens iD, Carlos H Souza, Marine Traverson, Pierre Amsellem, Elroy Williams, Owen T Skinner und 3 weitere

Veterinary and Comparative Oncology · 2023-12 · 21 (4) · 673-684

DOI: 10.1111/vco.12931 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 31.08.2023. Verfasst von Hunter J Piegols und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Veterinary Medical Center, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Dog Diseases, Pheochromocytoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adrenalectomies for canine adrenal tumours are associated with peri‐operative morbidity and mortality. Objectives of this study included assessing the prognostic value of tumour‐ or surgery‐related variables in predicting peri‐operative mortality and overall survival in dogs undergoing adrenalectomies for primary adrenal tumours as well as pre‐treatment with phenoxybenzamine on survival to discharge with pheochromocytomas specifically. A multi‐institutional retrospective cohort study was performed across nine institutions. Electronic medical record searches identified 302 dogs which met the inclusion criteria. Data collected included dog‐related, tumour‐related, treatment‐related, surgery‐related, and outcome variables. Univariate and multivariable logistic regression and cox proportional hazards models were used to identify variables associated with death prior to discharge and tumour‐related survival. Overall, 87% of dogs survived to discharge with a tumour‐related survival time of 3.96 years. Post‐operative complications were reported in 25%. Increased surgical time ( p = 0.002) and pre‐surgical medical treatment other than phenoxybenzamine ( p = 0.024) were significantly associated with increased peri‐operative mortality while ureteronephrectomy ( p = 0.021), post‐operative pancreatitis (p = 0.025), and post‐operative aspiration pneumonia ( p < 0.001) were significantly associated with decreased overall survival. Phenoxybenzamine pretreatment had no effect on peri‐operative mortality. Thirty‐seven of 45 (82%) dogs with pheochromocytomas not pretreated survived to discharge, and 50 of 59 (85%) dogs with pheochromocytomas pretreated with phenoxybenzamine survived to discharge ( p = 0.730). This study provides information on risk factors for death prior to discharge and tumour‐related survival that may help guide clinical management and owner expectations. In addition, the study findings challenge the previously reported benefit of phenoxybenzamine for pretreatment of dogs undergoing adrenalectomies for pheochromocytomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Gland NeoplasmsDog DiseasesPheochromocytomaAnimalsDogsAdrenalectomyPatient DischargePhenoxybenzamineRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

adrenal glandsadrenalectomydogsphenoxybenzaminepheochromocytoma

Substanzen

Phenoxybenzamine

Autor:innen und Institutionen

  • The Ohio State University Veterinary Medical Center, The Ohio State University, Columbus, Ohio, USA.
  • Ryan Veterinary Hospital, Unviersity of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Angell Animal Medical Center, Boston, Massachusetts, USA.
  • Texas A&M University Small Animal Teaching Hospital, Texas A&M University, College Station, Texas, USA.
  • UF Small Animal Hospital, University of Florida, Gainesville, Florida, USA.
  • NC State Veterinary Hospital, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Brandan G Wustefeld-Janssens, Julius M Liptak, Laura E Selmic

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Piegols, H. J., Abrams, B. E., Lapsley, J. M., Cray, M. T., Dornbusch, J. A., Murphy, C., Wustefeld-Janssens, B. G., Souza, C. H., Traverson, M., Amsellem, P., Williams, E., Skinner, O. T., Liptak, J. M., Stephens, J. A., & Selmic, L. E. (2023). Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours. Veterinary and Comparative Oncology, 21(4), 673-684. https://doi.org/10.1111/vco.12931

Vancouver

Piegols HJ, Abrams BE, Lapsley JM, Cray MT, Dornbusch JA, Murphy C, et al. Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours. Veterinary and Comparative Oncology. 2023;21(4):673-684. doi:10.1111/vco.12931

BibTeX
@article{Piegols2023,
  author = {Piegols, Hunter J and Abrams, Brittany E and Lapsley, Janis M and Cray, Megan T and Dornbusch, Josephine A and Murphy, Christina and Wustefeld-Janssens, Brandan G and Souza, Carlos H and Traverson, Marine and Amsellem, Pierre and Williams, Elroy and Skinner, Owen T and Liptak, Julius M and Stephens, Julie A and Selmic, Laura E},
  title = {Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours},
  journal = {Veterinary and Comparative Oncology},
  year = {2023},
  volume = {21},
  number = {4},
  pages = {673--684},
  doi = {10.1111/vco.12931}
}
Kostenlos starten →